P—糖蛋白与类风湿关节炎多药耐药的关系的研究进展(3)
 |
| 第1页 |
参见附件。
[14] Oerlemans R，Dijkmans BAC，van der Heijden u，et al. Differential expression of multidrug resistance-related proteins on monocyte-derived macrophages from rheumatoid arthritis patients[J].Arthritis Res Ther，2005，7：83.
[15] Jorgensen C， Sun R， Rossi JF， et al.Expression of a multidrug resistance gene in human rheumatoid synovium[J]. Rheumatol Int，1995，15(2)：83-86.
[16] Llorente L， Richaud-Patin Y， Diaz-Borjon A， et al. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I： Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome[J]. Joint Bone Spine， 2000，67(1)：30-39.
[17] 陈伟进， 阳婕， 毛妮，等. P-糖蛋白与类风湿关节炎多药耐药的相关研究[J].中华风湿病学杂志， 2010，14(4)： 248-251.
[18] Maillefert JF， Maynadie M， Tebib JG， et al. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone[J]. Br J Rheumatol， 1996，35(5)：430-435.
[19] Tsujimura S， Saito K， Nawata M， et al.，Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis[J]. Ann Rheum Dis，2008， 67(3)：380-388.
[20] Farooqui AN， Ahmad SL， Mansuri FA. Efficacy of cyclosporin-A in refractory rheumatoid arthritis[J]. J Coll Physicians Surg Pak，2004，14(3)：139-141.
[21] Johns KR， Littlejohn GO. The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis[J]. J Rheumatol，1999 ，26(10)：2110-2113.
[22] Suzuki K， Saito K， Tsujimura S， et al. Tacrolimus， a calcineurin inhibitor， overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis[J].JRheumatol，J Rheumatol，2010，37(3)：512-520.
您现在查看是摘要介绍页，详见PDF附件。